Page last updated: 2024-08-25

suplatast tosilate and Nasal Diseases

suplatast tosilate has been researched along with Nasal Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adachi, T; Das, AK; Fukui, H; Kadota, T; Kitamura, Y; Kominami, T; Kosaka, T; Matsumoto, M; Miyagi, K; Mizuguchi, H; Orimoto, N; Sawada, A; Takeda, N; Tamada, M	1

Other Studies

1 other study(ies) available for suplatast tosilate and Nasal Diseases

Article	Year
Suplatast tosilate alleviates nasal symptoms through the suppression of nuclear factor of activated T-cells-mediated IL-9 gene expression in toluene-2,4-diisocyanate-sensitized rats. Journal of pharmacological sciences, 2016, Volume: 130, Issue:3 Topics: Animals; Anti-Allergic Agents; Arylsulfonates; Calcineurin; Cells, Cultured; Drug Therapy, Combination; Gene Expression; Histamine Antagonists; Hypersensitivity; Interleukin-9; Male; NFATC Transcription Factors; Nose Diseases; Rats; Receptors, Histamine H1; Signal Transduction; Sulfonium Compounds; Toluene 2,4-Diisocyanate	2016

Article

Year

Suplatast tosilate alleviates nasal symptoms through the suppression of nuclear factor of activated T-cells-mediated IL-9 gene expression in toluene-2,4-diisocyanate-sensitized rats.

Journal of pharmacological sciences, 2016, Volume: 130, Issue:3

Topics: Animals; Anti-Allergic Agents; Arylsulfonates; Calcineurin; Cells, Cultured; Drug Therapy, Combination; Gene Expression; Histamine Antagonists; Hypersensitivity; Interleukin-9; Male; NFATC Transcription Factors; Nose Diseases; Rats; Receptors, Histamine H1; Signal Transduction; Sulfonium Compounds; Toluene 2,4-Diisocyanate

2016